coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Mid Furness PCN, Westmorland and Furness (LAD) · Health Inequalities Profile

    PCN U25520 · NHS Lancashire and South Cumbria Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    30,348

    Registered population

    57.8% aged 18–64

    26.0%

    Aged 65+

    ICB 20.0% · England 17.9%

    1.9%

    Ethnic minority (non-White)

    0.8% Asian

    0.0%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    5,539

    Hypertension register

    +7.43% in 3 yrs · England +5.60%

    293

    SMI register

    13.3% of Westmorland and Furness (LAD)'s

    560

    COPD register

    Reviews -5.12% in 3 yrs

    Forecast to 2030

    6,509

    Hypertension patients, 2030

    +970 on today

    59.8%

    QRISK ≥20% on statins, 2030

    +2.04pp over 3 yrs

    6.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -6.2%
    COPD register and review rates contracted.

    COPD prevalence fell 6.2% over three years (England +2.6%) and annual reviews fell 5.1% (England +2.8%), with a +15 to +52 modelled gap.

    55.5%
    High-risk lipid therapy and SMI checks trail.

    Only 55.5% of QRISK ≥ 20% patients receive lipid therapy (England 63.6%), while SMI blood pressure (76.3%) and BMI (74.1%) checks trail England.

    +19.9%
    Heart failure reviews and BP control grew.

    Heart failure reviews rose 19.9% over three years to 83.5% (England 78.5%), and hypertension treatment to target rose 7.1% to 70.9% (England 70.3%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ make up 26.0% of the list, well above England's 17.9%

    Mid Furness PCN serves 30,348 registered patients across four practices. Patients aged 65+ represent 26.0% of the list (7,902 patients), above Westmorland and Furness (25.9%), the ICB (20.0%) and England (17.9%). Children aged 0-17 comprise 16.2% (4,909 patients; LAD 15.8%, ICB 19.6%, England 19.6%), and working-age adults 57.8% (17,537 patients; LAD 58.4%, ICB 60.4%, England 62.7%). Census usual resident data shows 98.1% White and a 1.9% ethnic minority share, though this reflects local residents rather than registered patients. Projected population growth to 2030 is 1.2% (LAD 1.7%, ICB 1.7%, England 2.3%), under an unverified methodology.

    Age profile

    0–1716.2%
    18–6457.8%
    65+26.0%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White98.1%
    Mixed0.8%
    Asian0.8%
    Other0.2%
    Black0.1%

    Older people · falls rows are Westmorland and Furness (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Westmorland and Furness LA)1,5912,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.1%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)61.4%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Westmorland and Furness LA)7361,0219552024/25
    Falls deaths, all ages, per 100,000 (Westmorland and Furness LA)10.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Zero registered patients live in Core20 areas, but severe mental illness checks lag England

    The PCN records 0.0% of registered patients (0 patients) in the Core20 cohort, compared with 9.2% in Westmorland and Furness, 30.6% in the ICB, and 21.0% in England, with an average IMD decile of 6.3 (England 5.5). While area deprivation is low, routine monitoring for 293 severe mental illness patients trails national rates: blood pressure checks reach 76.3% (England 83.4%), BMI 74.1% (England 82.1%), and alcohol recording 64.2% (England 81.8%). Lower check completion rates among patients with severe mental illness indicate an opportunity to review routine annual monitoring pathways.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Ulverston Medical0.0% · 0 patients
    Dalton0.0% · 0 patients
    Ulverston0.0% · 0 patients
    Duddon Valley0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    293

    SMI register

    0.96% recorded prevalence

    133

    Learning disability register

    0.44% recorded prevalence

    8

    Care homes, 289 beds

    In the PCN catchment

    Mid Furness records 293 patients on the severe mental illness register (1.0%, England 1.0%) and 133 on the learning disability register (0.4%, England 0.6%). The catchment includes 8 care homes (289 beds), while Westmorland and Furness recorded 14 rough sleepers in autumn 2025. Illustrative register gap modelling suggests 35 to 45 learning disability patients against borough and England benchmarks, though this does not indicate confirmed under-detection.

    Severe mental illness: physical health checks

    Recorded SMI prevalence is 1.0% (293 patients). Physical checks trail England: 76.3% had blood pressure checked (England 83.4%, dropping to 62.1% at Ulverston Community Health Centre) and 74.1% had BMI recorded (England 82.1%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,539

    Hypertension register

    +7.43%

    Register growth, 3 yrs

    Westmorland and Furness (LAD) +6.93% · England +5.60%

    +4.42pp

    BP control, under 80

    ≤140/90 · +4.11pp aged 80+

    +970

    More patients by 2030

    Forecast 6,509 (21.00%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 18.2% (5,539 patients), matching Westmorland and Furness (18.2%) and exceeding the ICB (17.2%) and England (15.2%), though crude rates are not age-adjusted. Blood pressure monitoring is 90.1% (England 90.0%). Blood pressure control for patients under 80 is 66.9%, trailing England (67.8%) and the borough (68.0%), and dropping to 65.8% at Ulverston Medical Practice. Lower control than England indicates an opportunity to expand home monitoring titration and review at lagging practices.

    Lipids and statins

    Primary prevention lipid therapy reaches 55.5% of patients with QRISK ≥ 20% and 68.2% with diabetes aged 40+ without CVD, trailing England (63.6% and 73.2%). Lower reach than England suggests an opportunity to audit lipid initiation across both cohorts.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202648,594£2.20£1.64£1.86£106,907
    Cardiovascular (all), 202571,551£5.38£3.38£3.33£384,944

    For Lipid-regulating drugs 2026, the PCN prescribed 48,594 items at £2.20 per item, above England (£1.86) and the ICB (£1.64), spending £27,213 more than at ICB unit cost. Higher unit cost than ICB benchmarks highlights an opportunity to review formulary selection alongside expanding treatment reach.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +1.57%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.81%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 1.8% (560 patients; England 1.9%, LAD 2.0%), falling 6.2% over three years (England +2.6%). Annual reviews reached 77.5% (England 76.4%), but fell 5.1% over three years (England +2.8%). A benchmark model suggests a register gap of +15 to +52 patients. Asthma prevalence is 8.2% (2,392 patients; England 6.6%) and reviews reached 74.2% (England 65.7%), leaving about 620 unreviewed. Contraction could reflect list validation or under-detection, which clinical audit would test.

    Cancer register and children's immunisation

    Cancer prevalence is 5.1% (1,562 patients), above England (3.8%). Childhood immunisations exceed benchmarks: 6-in-1 coverage at 12 months is 94.9% (59 children), 0.1 pp below the 95.0% target, reaching 98.1% at 24 months. At age 5, MMR first-dose coverage is 100.0% but second-dose uptake drops 2.3 pp to 97.7%, indicating an opportunity to eliminate pre-school second-dose drop-off.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.9%

    England 91.0%

    6-in-1 complete primary course at 24 months98.1%

    England 92.2%

    MMR dose 1 at 24 months98.1%

    England 88.3%

    MMR dose 2 at age 597.7%

    England 82.8%

    4-in-1 pre-school booster at age 597.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    Across NHS Lancashire and South Cumbria ICB in 2022, 52.4% of cancers with a known stage (4,642 of 8,863) were diagnosed at stage 1 or 2, below England (55.3%) and 22.6 pp below the 75.0% national ambition. Reaching that ambition requires about 2,010 extra early-stage diagnoses annually across the ICB. Known-stage cancers comprised 74.6% of 11,883 registrations, exceeding England (67.0%). Early presentation varied: breast was 86.0%, lung was 31.1% and oesophagus was 11.1%. These figures reflect ICB pathways rather than PCN performance. Local practices can support earlier detection by reviewing safety-netting protocols.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), University Hospitals of Morecambe Bay NHS Foundation Trust achieved 72.4% on the cancer 62-day referral to treatment standard, 12.6 pp below the 85.0% standard. This compared with 73.6% for NHS Lancashire and South Cumbria Integrated Care Board, 71.2% in England, 70.9% at North Cumbria Integrated Care NHS Foundation Trust, and 67.5% at Blackpool Teaching Hospitals NHS Foundation Trust. The trust met the 75.0% 28-day faster diagnosis standard at 78.4% (ICB 78.4%, England 79.3%). For diagnostics, colonoscopy 6-week waits stood at 0.6% (England 30.8%) and CT at 13.8% (England 9.9%).

    Pathways within standard (%)of Morecambe BayBlackpoolNorth Cumbria Integrated CareLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)78.3971.3878.3378.3979.32
    31-day treatment (96%)95.2297.9693.0993.6292.50
    62-day referral to treatment (85%)72.3567.4870.9073.6271.16
    Diagnostic waits over 6 weeks (%)of Morecambe BayBlackpoolNorth Cumbria Integrated CareEngland
    MRI4.0421.809.5921.40
    CT13.7616.490.639.92
    Echocardiography10.557.571.3328.48
    Colonoscopy0.6013.085.5030.83
    Gastroscopy1.4512.4710.9029.02
    All 15 DM01 tests10.4426.5416.6023.14
    Community services activityWestmorland and Furness residentsLancashire and South Cumbria ICB
    Care contacts53,485193,720
    Referrals6,47029,855
    Patients with a contact13,44565,335

    Community services (residents of Westmorland and Furness), Jun 2026 (provisional). In Jun 2026 (provisional), community service activity for Westmorland and Furness residents recorded 53,485 total contacts, with 36,330 involving adults aged 65 and over, representing 67.9% of all contacts. These data reflect activity across the local authority rather than PCN-registered patients, showing substantial older-age community caseloads across the wider care system.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, overall QOF achievement exceeds England (92.5%) across all practices, from 96.3% at Ulverston Community Health Centre to 97.9% at Duddon Valley Medical Practice. Vaccination and immunisation achievement varies by 24.8 pp, from 68.6% at Ulverston Community Health Centre to 93.5% at Ulverston Medical Practice, while all exceed England (55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Ulverston1070.074.6%76.8%89.2%
    Duddon Valley1150.079.3%69.2%84.6%
    Ulverston Medical1110.065.7%73.6%83.4%
    Dalton Surgery1170.036.9%82.9%81.7%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWestmorland and Furness (LAD)AssetPCNWestmorland and Furness (LAD)
    Care homes (catchment)8 (289 beds)n/aSchools (catchment)34n/a
    Children's centres212Places of worship37316
    Libraries214Food banks (VCS)n/a2
    Day centres (VCS)n/a2Children and young people (VCS)n/a3
    Carers support groups (VCS)n/a2Primary schools (LA maintained)1182
    Primary academies527Special schools14

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Validate COPD register and reviews

    COPD prevalence is 1.8% (560 patients; LAD 2.0%, England 1.9%), falling 6.2% over 2023 to 2025 (England +2.6%), with a modelled gap of +15 to +52 patients. For discussion: audit patients on repeat respiratory prescribing without a COPD code, combine annual review recall, and raise spirometry access with system partners. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 2

    Standardise SMI physical health recall

    For 293 severe mental illness patients, blood pressure checks reach 76.3% (England 83.4%, Ulverston Community Health Centre 62.1%), BMI 74.1% (England 82.1%) and alcohol recording 64.2% (England 81.8%). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Review lipid initiation and BP titration

    Lipid therapy reaches 55.5% for QRISK ≥ 20% (England 63.6%). Under-80 hypertension BP control is 66.9% (England 67.8%, Ulverston Medical Practice 65.8%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Mental health physical check outreach (p3)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Severe mental illness health checks (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure control review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school second dose recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer safety netting audit (p7)Cancers diagnosed at stage 1 or 2 (All cancer sites)—ICB
    Option 1 · Validate COPD register and reviews (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Option 2 · Standardise SMI physical health recall (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN & Practice
    Option 3 · Review lipid initiation and BP titration (p12)Hypertension register · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) · Patients with QRISK ≥ 20% treated with lipid lowering therapyCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15